Innovation Designed for What Comes Next
Innovation begins with a clear purpose—transforming scientific insight into high-quality, affordable medicines for patients. Our R&D strategy combines scientific rigor, regulatory excellence, and commercial focus to develop products that are efficient to manufacture, scalable to produce, and ready for the U.S. market.
Our Formulation R&D and Analytical R&D (AR&D) teams in Chantilly, Virginia work alongside specialized research hubs across the United States and India, each contributing expertise in formulation science, analytical development, process chemistry, and active pharmaceutical ingredients (APIs). This collaborative model brings together specialized knowledge while maintaining close coordination across every stage of development.
A key differentiator is our vertically integrated research approach. Rather than developing formulations around existing ingredients, our API scientists work in parallel with formulation teams to develop and optimize active pharmaceutical ingredients specifically for targeted products. This integrated process strengthens quality, improves efficiency, accelerates development, and creates a smoother path from laboratory to commercial manufacturing.
Throughout the development lifecycle, multidisciplinary teams of chemists, analysts, formulation scientists, and process engineers collaborate to advance a diverse pipeline of generic and over-the-counter medicines. Guided by green chemistry principles and continuous process optimization, our R&D organization delivers innovations that are not only scientifically advanced but commercially viable, environmentally responsible, and built for long-term success.
